Rapid Extraction Method of Mycobacterium ulcerans DNA from Clinical Samples of Suspected Buruli Ulcer Patients.
Michael FrimpongHubert Senanu AhorSamuel Asamoah SakyiBernadette AgbavorEmmanuel AkowuahRichard Odame PhillipsPublished in: Diagnostics (Basel, Switzerland) (2019)
Isothermal amplification techniques such as recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP) for diagnosing Buruli ulcer, a necrotic skin disease caused by Mycobacterium ulcerans, have renewed hope for the molecular diagnosis of clinically suspected Buruli ulcer cases in endemic districts. If these techniques are applied at district-level hospitals or clinics, they will help facilitate early case detection with prompt treatment, thereby reducing disability and associated costs of disease management. The accuracy as well as the application of these molecular techniques at point of need is dependent on simple and fast DNA extraction. We have modified and tested a rapid extraction protocol for use with an already developed recombinase polymerase amplification assay. The entire procedure from "sample in, extraction and DNA amplification" was conducted in a mobile suitcase laboratory within 40 min. The DNA extraction procedure was performed within 15 min, with only two manipulation/pipetting steps needed. The diagnostic sensitivity and specificity of this extraction protocol together with M. ulcerans RPA in comparison with standard DNA extraction with real-time PCR was 87% (n = 26) and 100% (n = 13), respectively. We have established a simple, fast and efficient protocol for the extraction and detection of M. ulcerans DNA in clinical samples that is adaptable to field conditions.
Keyphrases
- loop mediated isothermal amplification
- nucleic acid
- circulating tumor
- single molecule
- cell free
- real time pcr
- sensitive detection
- randomized controlled trial
- mycobacterium tuberculosis
- primary care
- label free
- end stage renal disease
- multiple sclerosis
- healthcare
- south africa
- chronic kidney disease
- newly diagnosed
- circulating tumor cells
- prognostic factors
- structural basis
- peritoneal dialysis